MergerLinks Header Logo

Submit Deal

Submit Deal

Announced

Completed

Novo and Bioqube Ventures led an €11m investment in Commit Biologics.

Synopsis

Novo, a life science investor, and Bioqube Ventures, a specialist life sciences investment firm, led an €11m investment in Commit Biologics, a biotech spin-out from Aarhus University.

Principals

Commit Biologics

target

Commit Biologics

Novo Holdings

bidder

Novo Holdings

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Dealmakers (5)

Service Providers

Sort

Kasim Kutay

Kasim Kutay

InvestorCEO at NOVO HOLDINGS A/S
Deal Bio
Total Deals
27/
Total Value
£26,731M
Nico Vandervelpen

Nico Vandervelpen

ManagerCo-Founder and Managing Partner at BIOQUBE VENTURES
Deal Bio
Total Deals
2/
Total Value
£99M
Niels Bang

Niels Bang

LawyerPartner at Gorrissen Federspiel
Deal Bio
Total Deals
32/
Total Value
£10,496M
Nick Stub Laursen

Nick Stub Laursen

ManagerCSO and Co-founder at COMMIT BIOLOGICS
Deal Bio
Total Deals
1/
Total Value
£9M
Caroline Boysen

Caroline Boysen

LawyerAssociate at Gorrissen Federspiel
Deal Bio
Total Deals
14/
Total Value
£7,006M

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US